REFRACTORY NewsLatest News On REFRACTORY Tafasitamab Plus Lenalidomide and Rituximab Improves Progression-Free Survival in Relapsed or Refractory Follicular Lymphoma12/17/2024 11:45 PM Vagus Nerve Stimulation Proves Effective in Refractory Rheumatoid Arthritis11/21/2024 6:22 AM Aggressive Infliximab Dosing Shows No Added Benefit in Acute Severe Ulcerative Colitis11/19/2024 4:37 AM Multi-Refractory MM: After Immunotherapy, What?10/25/2024 7:49 AM Intraosseous Access Simplified: Tips for Saving Lives10/21/2024 2:39 PM Methotrexate in Atopic Dermatitis: Experts Clarify Dosage10/9/2024 2:47 AM A Measured Approach Key to Treating Mycosis Fungoides10/4/2024 7:14 AM Lutetium-177 Dotatate Shows Promise for Refractory Meningioma10/3/2024 9:23 AM Emapalumab Effective in Rheumatologic Disease–Associated Hemophagocytic Lymphohistiocytosis9/26/2024 1:46 AM Progress in Seborrheic Dermatitis Meaningful for Skin of Color9/18/2024 4:59 AM Metformin May Help Manage Central Centrifugal Cicatricial Alopecia, Study Suggests9/6/2024 7:14 AM Multiple Myeloma: New Treatments Aid Patient Subgroups8/12/2024 11:38 AM FDA Approves Lymphir for R/R Cutaneous T-Cell Lymphoma8/9/2024 4:27 AM Will ECPR Move the Needle on Cardiac Arrest Survival?8/6/2024 11:17 AM Accelerated Brain Stimulation Rapidly Curbs Resistant Bipolar Depression7/17/2024 5:52 AM New Options for Refractory Gout Are Showing Promise in Late-Phase Trials7/9/2024 6:11 AM Dupilumab Effective in PPI-Refractory Pediatric EoE7/4/2024 5:19 AM FDA Approves Epcoritamab for R/R Follicular Lymphoma6/27/2024 7:43 AM What's in a Name: Defining Difficult-to-Treat axSpA and PsA6/14/2024 7:57 AM Myeloma: First-in-Class ADC Regimen Yields Key Benefits6/7/2024 4:33 AM
